Steve Pells

Steve Pells

Company: ReNeuron

Job title: Principal Investigator, Molecular Biology Group


Conditionally-Immortalised iPSCs: A New Approach to Off-the-Shelf Allogeneic iPSC-Derived Cell Therapies 4:00 pm

Reprogramming conditionally immortalised adult stem cells to pluripotency generates true iPSCs with some unique properties Use of the conditional immortalisation technology to produce clinically-relevant cells such as tissue progenitors: proof-of-principle for a system to manufacture (iPSC-derived) specific cell types at scale Towards GMP conditionally-immortalised iPSCs: clinical-grade, bankable, adult stem cells and other therapeutic cells for…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.